Peter Birner, Stefan Pusch, Christo Christov, Stiliana Mihaylova, Kalina Toumangelova-Uzeir, Sevdalin Natchev, Sebastian F. Schoppmann, Andrey Tchorbanov, Berthold Streubel, Jochen Tuettenberg and Marin Guentchev Mutant IDH1 inhibits PI3K/Akt signaling in human glioma Cancer 120
Article first published online: 25 APR 2014 | DOI: 10.1002/cncr.28732
Isocitrate dehydrogenase 1 (IDH1) is a major player in glioma pathogenesis with an unknown signaling pathway allocation. This study provides several lines of evidence that mutant IDH1 influences PI3K (phosphoinositol 3-kinase)/Akt signaling.
Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf
Required = Required Field
Choose captcha format: Image or Audio. Click here if you need help.